High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter
Clinical
Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina
Articles
Eyeviews
Medical World News
Podcasts
Rapid Readouts
Viewpoints
Digital Edition
Supplements And Featured Publications
Conference Listing
CME/CE
Sponsored
Zeiss Case Studies
Roche Video Series
Print Subscription
eNewsletter
Advertisement
Sirion launches trial
Sirion Therapeutics has begun enrolment for a Phase II trial of the compound fenretinide, as a treatment for geographic atrophy in patients with age-related macular degeneration.